Business
First approval for ATL1102 Phase IIb DMD clinical trial
First approval for ATL1102 Phase IIb DMD clinical trial
About this update from Percheron Therapeutics Limited
[{"type":"text","content":"Percheron Therapeutics Limited has released a press release. View Attachment","length":256,"tagName":"div"}]